We like one of these upcoming spinoffs

Article Excerpt

Spinoffs are a great way for companies to boost shareholder value. Here’s our take on two spinoffs coming up in the second half of 2024. BAXTER INTERNATIONAL INC. $36 is a buy. The company (New York symbol BAX; Manufacturing sector; Shares o/s: 507.8 million; Market cap: $18.3 billion; Dividend yield: 3.2%; Takeover Target Rating: Medium; www.baxter.com) makes a variety of medical devices, including intravenous pumps and kidney-dialysis equipment. Under a new strategy to narrow its focus to specialized equipment for hospitals, including intensive-care-unit beds, operating tables, patient monitoring equipment and electronic diagnostic systems, Baxter is shedding some of its other businesses. As part of that strategy, Baxter plans to spin off later this year its Renal Care and Acute Therapies unit as a separate firm called Vantive. That business makes kidney dialysis machines and related equipment, and accounts for 30% of Baxter’s total revenue. However, according to media reports, investment firm Carlyle Group Inc. (Nasdaq symbol CG) has now offered to buy Vantive for over $4 billion…